Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

NCT05834426 is registered in ClinicalTrials.gov with Sociedad de Lucha Contra el Cáncer del Ecuador as lead sponsor.

NCT NCT05834426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05834426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers
Lead sponsor
Sociedad de Lucha Contra el Cáncer del Ecuador
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2023
Completion date
August 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, diffuse large b cell lymphoma, high-grade b-cell lymphoma, lymphoma, b-cell, metabolomics, neoplasms, non hodgkin lymphoma